Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. - Wikidata - wikimedia - TriplyDB

Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

http://www.wikidata.org/entity/Q34976967

about

Molecular cancer prevention: Current status and future directions Reconstructing skin cancers using animal models Secondary solid cancer screening following hematopoietic cell transplantation Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches Pharmacotherapy of actinic keratosis.Impact of interval and combination therapies on the management of actinic keratosis: review and clinical considerations.Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp The impact of the current United States guidelines on the management of actinic keratosis: is it time for an update?Actinic keratosis: rationale and management Field treatment of facial and scalp actinic keratoses with photodynamic therapy: survey of patient perceptions of treatment satisfaction and outcomes.Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin Non-ablative fractional resurfacing in combination with topical tretinoin cream as a field treatment modality for multiple actinic keratosis: a pilot study and a review of other field treatment modalities.Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.The natural history of actinic keratosis: a systematic review.Pharmacotherapy of actinic keratosis: an update.Nicotinamide and the skin.Actinic keratosis: update on field therapy.Histopathological variants of cutaneous squamous cell carcinoma: a review.Another approach to actinic keratosis management using nonablative fractional laser.Assessment of local skin reactions with a sequential regimen of cryosurgery followed by ingenol mebutate gel, 0.015%, in patients with actinic keratosis Automated detection of actinic keratoses in clinical photographs.Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.Squamous cell cancer--31-year epidemiological study in a city of south Brazil.Genomic analysis of metastatic cutaneous squamous cell carcinoma.A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.Italian expert consensus for the management of actinic keratosis in immunocompetent patients.Evaluation of the prognostic significance of follicular extension in actinic keratoses.Two Cases of Cutaneous Squamous Cell Carcinoma Arising in Immunosuppressed Patients with Chronic Human Papillomavirus Infection Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates.Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate.New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.Comprehensive review of ultraviolet radiation and the current status on sunscreens.An Investigator-initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses on Dorsal Hands and Forearms.In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 Patients Fractionation of a tumor-initiating UV dose introduces DNA damage-retaining cells in hairless mouse skin and renders subsequent TPA-promoted tumors non-regressing Tolerability of Ingenol Mebutate Gel, 0.05%, for Treating Patients with Actinic Keratosis on the Scalp in a Community Dermatology Practice.A 10-Year Retrospective Analysis of Methyl Aminolevulinate Photodynamic Therapy Consultation at the Hospital de Braga.

P2860

Q26797207-87124DF6-5A6C-4822-9E4B-BC8CCF43981E Q27024320-3115FC69-662F-4906-A88D-7F4087AAE863 Q28088369-BCB35966-5C5E-4AC0-B2FF-E99E5255A4DD Q30238649-7105799E-054A-41E9-B153-7560757AB6A5 Q30898080-B2FD34D3-5362-45D8-AD50-A7ADA35C0FDF Q33596422-4FBD9AAA-D927-478C-B45C-F0583EDDA8A5 Q33631870-D9D4E1DF-FAC7-404C-8175-EFDE9FD87AA5 Q33754497-3ACF6525-9B2A-4FE2-A32B-7587B6D756D7 Q33785049-BC1434EF-5645-4958-AB99-5690E4EC7F3E Q33990753-D1DBBB58-3B45-483E-82E5-39AE6A132E86 Q34179222-7D33834B-269A-4824-B439-DFAECE262288 Q34239385-0965C3E1-5543-48A1-B7A6-BAA415304789 Q34299210-695C3F28-39B9-4279-9EAD-6C201508DD5A Q34343144-B4572FC2-B752-4A9D-BFEA-90B18A8E21C7 Q34378153-FC9BE4F9-23D6-4265-B2EA-96A233ED6A06 Q34410433-B0BCAD22-A351-4F82-AF55-F8C5FA293157 Q34441431-4136A573-AECA-4B18-B0DA-AD551E98498E Q34479227-B5B60AEB-F206-4857-ABE3-9D9AC66F9548 Q34553843-B430CC2F-0437-44C4-9E52-0B3FFD86CDF9 Q34757193-4A4BEA7E-59D3-4F59-9ED0-135192D9780B Q35006877-BF9BE1C0-C657-4E8D-B2D0-1FD0D9865D0E Q35044103-5F4C0385-1991-4F73-8769-2A9AAD727024 Q35066454-2D6FCDAE-BAE6-4131-9396-77AABF78CE5B Q35070284-CE36B2E0-B6BD-42FD-A0C3-1842F53A5272 Q35178368-E44AE63B-0C79-46CB-AE88-AB4D1864A637 Q35180653-55249157-5E83-407F-A8EA-B0419669236B Q35635404-0CA7AA9D-F5E2-4123-B78A-993C84812D4B Q35698913-38662D46-4778-4231-8E67-86A7DF2AA015 Q35984429-82BED8AA-FEBC-4D91-AE9F-E2AEFF0F939D Q36005531-DAE4B6CA-C4D9-44B8-85FB-24657204D25A Q36028671-4991997C-1181-4970-BC93-57AD052C13B2 Q36116513-B16239B1-2A2F-4D29-9169-BD50D6033A58 Q36128569-A3F2683D-5D94-4471-B3B4-79F8B7882D6B Q36196699-2FD3EC68-C286-4102-8FCA-CDDB57EED3A3 Q36286783-F8E0D1AB-8485-4C9C-A431-AAFE2A24E92D Q36630030-55034001-FA9E-4419-A8AB-FD86153221EA Q36631465-3F89D077-B4D0-4DD8-B2A6-F4938DB2DB48 Q36946719-5A665358-449B-40D4-9B00-ED89CB409E72 Q36978521-4E1D850C-784A-43C3-8A69-8F9B48609811 Q36999991-7011680B-3119-4CEF-9354-51C6E42F7B7F

P2860

Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

http://www.wikidata.org/entity/Q34976967

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@ast

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@en

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@nl

type

label

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@ast

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@en

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@nl

prefLabel

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@ast

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@en

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@nl

P1433

Q34976967-0E86CEE3-E224-4E30-A639-BC6459D77D9C

P1476

Q34976967-51D90877-6916-4C8F-8F30-86FED3454CD8

P2093

Q34976967-15A214FA-C365-4994-8DF9-1D9DEB22B830

Q34976967-2D25004E-AAA8-482A-B7A9-9C93D1204EBE

Q34976967-46F6BFBA-0B55-431E-B9AE-4B3049A997F9

Q34976967-48963D68-5CAA-4280-96B8-58388605FC22

Q34976967-59400857-1FC0-425A-BFDE-89C95B06CC1B

Q34976967-A9C71551-3A25-484C-8791-738B753B7168

Q34976967-C719E03F-5142-4A27-BFE7-014B14046FDE

P2860

Q34976967-AF1AF66F-0515-4890-9484-237FF0182D82

P304

Q34976967-CC3BDEE0-F5B8-432C-B2A6-99C7B76F84E0

P31

Q34976967-C76D97F7-0184-49C3-AF88-767D3FE61AF3

P356

Q34976967-55F598C5-BA5D-44A2-A8B9-23662C4E5EDE

P407

Q34976967-37D1FFFE-ED22-4F9A-9154-A117DD302548

P433

Q34976967-977C36F0-F73A-40C4-827D-046E0D240BAF

P478

Q34976967-7FC60A45-135F-4FA9-8574-377DA9C537BC

P577

Q34976967-AE6C1228-FAFE-4BFA-A658-64DE5252A830

P5875

Q34976967-30DBE4B3-BEDA-42AC-A76A-986699EF5C31

P698

Q34976967-31FC5C8D-98FD-4756-B2B7-20EBD7BFBE46

P921

Q34976967-DE5DFAF3-0511-4087-AE46-DD0EC0F1A47E

P356

P1433

P1476

Actinic keratoses: Natural his ...... etinoin Chemoprevention Trial.

@en

P2093

Claudia Luque

http://www.w3.org/2001/XMLSchema#string

Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group

http://www.w3.org/2001/XMLSchema#string

Mark F Naylor

http://www.w3.org/2001/XMLSchema#string

Martin A Weinstock

http://www.w3.org/2001/XMLSchema#string

Melody J Eide

http://www.w3.org/2001/XMLSchema#string

Stephen F Bingham

http://www.w3.org/2001/XMLSchema#string

Vincent D Criscione

http://www.w3.org/2001/XMLSchema#string

P2860

Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study.

P304

2523-2530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24284

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264300595

http://www.w3.org/2001/XMLSchema#string

P698

19382202

http://www.w3.org/2001/XMLSchema#string

P921